Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy-Reference-Cited by-同舟云学术

Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy

Published:2017-02-20 Issue:26 Volume:36 Page:3749-3759
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Castro B A,Flanigan P,Jahangiri A,Hoffman D,Chen W,Kuang R,De Lay M,Yagnik G,Wagner J R,Mascharak S,Sidorov M,Shrivastav S,Kohanbash G,Okada H,Aghi M K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc20171.pdf

Reference53 articles.

1. Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL et al. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 2012; 70: 361–370.

2. Bergers G, Hanahan D . Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592–603.

3. Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 2009; 27: 740–745.

4. DeLay M, Jahangiri A, Carbonell WS, Hu YL, Tsao S, Tom MW et al. Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy. Clin Cancer Res 2012; 18: 2930–2942.

5. Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol 2012; 14: 1379–1392.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies;Drug Development Research;2024-09

2. Cancer metastases: Tailoring the targets;Heliyon;2024-08

3. Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma;Oncotarget;2024-07-19

4. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07

5. Efficacy of Cisplatin–CXCR4 Antagonist Combination Therapy in Oral Cancer;Cancers;2024-06-25